APA (7th ed.) Citation

JM, W., H, N., GA, D., J, T., M, P., SF, M., . . . BJ, B. (2024). High-Throughput Screening for the Prevalence of Neutralizing Antibodies against Human Adenovirus Serotype 5. Vaccines, 12(2), . https://doi.org/10.3390/vaccines12020155

Chicago Style (17th ed.) Citation

JM, Wettengel, et al. "High-Throughput Screening for the Prevalence of Neutralizing Antibodies Against Human Adenovirus Serotype 5." Vaccines 12, no. 2 (2024). https://doi.org/10.3390/vaccines12020155.

MLA (9th ed.) Citation

JM, Wettengel, et al. "High-Throughput Screening for the Prevalence of Neutralizing Antibodies Against Human Adenovirus Serotype 5." Vaccines, vol. 12, no. 2, 2024, https://doi.org/10.3390/vaccines12020155.